412 related articles for article (PubMed ID: 6169060)
1. Serum levels of alpha-fetoprotein, human chorionic gonadotropin and carcinoembryonic antigen in patients with primary intracranial germ cell tumors.
Arita N; Ushio Y; Hayakawa T; Uozumi T; Watanabe M; Mori T; Mogami H
Oncodev Biol Med; 1980; 1(4-5):235-40. PubMed ID: 6169060
[TBL] [Abstract][Full Text] [Related]
2. [Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) in malignant germ cell tumors of the ovary using immunoperoxidase technique (author's transl)].
Obata N; Kodama S; Hando T; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):757-66. PubMed ID: 6165791
[TBL] [Abstract][Full Text] [Related]
3. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
[TBL] [Abstract][Full Text] [Related]
4. [Primary intracranial malignant germ cell tumor associated with abnormal high value of alpha-fetoprotein and human chorionic gonadotropin].
Nishiyama K; Nishida K; Kusaka K; Morizumi H
No Shinkei Geka; 1987 Dec; 15(12):1337-42. PubMed ID: 2452372
[TBL] [Abstract][Full Text] [Related]
5. Immunochemical determination of human chorionic gonadotropin and alpha-fetoprotein in sera and tumors of patients with testicular cancer.
Javadpour N; McIntire KR; Waldmann TA
Natl Cancer Inst Monogr; 1978 Dec; (49):209-13. PubMed ID: 86162
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
Kim A; Ji L; Balmaceda C; Diez B; Kellie SJ; Dunkel IJ; Gardner SL; Sposto R; Finlay JL
Pediatr Blood Cancer; 2008 Dec; 51(6):768-73. PubMed ID: 18802946
[TBL] [Abstract][Full Text] [Related]
8. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
Beck SD; Foster RS; Bihrle R; Donohue JP
Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
[TBL] [Abstract][Full Text] [Related]
9. The clinical significances of carcinoembryonic proteins in patients with ovarian carcinoma.
Tottori K; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):142-50. PubMed ID: 6164739
[TBL] [Abstract][Full Text] [Related]
10. Intracranial germ cell tumors: pathobiological and immunohistochemical aspects of 70 cases.
Bjornsson J; Scheithauer BW; Okazaki H; Leech RW
J Neuropathol Exp Neurol; 1985 Jan; 44(1):32-46. PubMed ID: 4038412
[TBL] [Abstract][Full Text] [Related]
11. Human chorionic gonadotropin in gastric carcinoma. A useful marker for bone metastasis.
Yonemura Y; Oyama S; Sugiyama K; Sawa T; Shima Y; Kamata T; Hashimoto T; Miwa K; Miyazaki I
Int Surg; 1989; 74(2):84-7. PubMed ID: 2473961
[TBL] [Abstract][Full Text] [Related]
12. [Malignant germ cell tumors in the mediastinum].
Miyake M; Ito M; Mitsuoka A; Wada H; Aoki M; Tamura K; Hitomi S
Nihon Geka Gakkai Zasshi; 1987 Mar; 88(3):340-8. PubMed ID: 2439890
[TBL] [Abstract][Full Text] [Related]
13. Oncofetal antigens in sacrococcygeal teratomas.
Kuhajda FP; Taxy JB
Arch Pathol Lab Med; 1983 May; 107(5):239-42. PubMed ID: 6188436
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
You B; Fronton L; Boyle H; Droz JP; Girard P; Tranchand B; Ribba B; Tod M; Chabaud S; Coquelin H; Fléchon A
Urology; 2010 Aug; 76(2):423-9.e2. PubMed ID: 20472276
[TBL] [Abstract][Full Text] [Related]
15. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
Lange PH
Natl Cancer Inst Monogr; 1978 Dec; (49):215-7. PubMed ID: 86163
[TBL] [Abstract][Full Text] [Related]
16. Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
Kobayashi T; Kawakita M; Terachi T; Habuchi T; Ogawa O; Kamoto T
J Surg Oncol; 2006 Dec; 94(7):619-23. PubMed ID: 17111392
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in metastatic nonseminomatous germ cell tumours.
Hanson PR; Belitsky P; Millard OH; Lannon SG
Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
[TBL] [Abstract][Full Text] [Related]
18. Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors.
Toner GC; Geller NL; Tan C; Nisselbaum J; Bosl GJ
Cancer Res; 1990 Sep; 50(18):5904-10. PubMed ID: 1697503
[TBL] [Abstract][Full Text] [Related]
19. Intracranial germ-cell tumors. Immunohistochemical study of three autopsy cases.
Naganuma H; Inoue H; Misumi S; Nakamura M; Tamura M
J Neurosurg; 1984 Nov; 61(5):931-7. PubMed ID: 6208344
[TBL] [Abstract][Full Text] [Related]
20. Immunohistological localization of AFP and HCG in uniformly classified testis tumors.
Wittekind C; Wichmann T; Von Kleist S
Anticancer Res; 1983; 3(5):327-30. PubMed ID: 6197005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
